Table 3.
Demographic and baseline characteristics
| MB study N = 6 | DDI/MT study N = 14 | MT sub-study N = 7 | ||
|---|---|---|---|---|
| Sex: female | N | 6 | 14 | 7 | 
| Race | ||||
| Asian | N | 0 | 1 | 0 | 
| White | N | 6 | 13 | 7 | 
| Age (years) | Mean (range) | 57.7 (49–63) | 58.9 (49–69) | 61.0 (55–69) | 
| Weight (kg) | Mean ± SD | 62.1 ± 7.33 | 67.3 ± 8.02 | 68.4 ± 8.50 | 
| BMI (kg/m2) | Mean ± SD | 23.1 ± 2.37 | 26.0 ± 2.66 | 26.4 ± 3.11 | 
| FSH > 40 IU/L | N | 6 | 14 | 7 | 
BMI body mass index, DDI drug–drug interaction, FSH follicle-stimulating hormone, MB mass balance, MT microtracer, SD standard deviation